| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An artificial intelligence model predicts the survival of solid tumour patients from imaging and clinical data
|
Schutte, Kathryn
|
|
|
174 |
C |
p. 90-98
|
artikel
|
| 2 |
Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study
|
Wang, Qiao-Xuan
|
|
|
174 |
C |
p. 176-184
|
artikel
|
| 3 |
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study
|
Basak, Edwin A.
|
|
|
174 |
C |
p. 113-120
|
artikel
|
| 4 |
Breast cancer mortality of older patients with and without recurrence analysed by novel multi-state models
|
de Boer, Anna Z.
|
|
|
174 |
C |
p. 212-220
|
artikel
|
| 5 |
Colon cancer CT staging according to mismatch repair status: Comparison and suggestion of imaging features for high-risk colon cancer
|
Hong, Eun Kyoung
|
|
|
174 |
C |
p. 165-175
|
artikel
|
| 6 |
Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials
|
Fulgenzi, Claudia A.M.
|
|
|
174 |
C |
p. 57-67
|
artikel
|
| 7 |
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group
|
Antonarelli, Gabriele
|
|
|
174 |
C |
p. 31-36
|
artikel
|
| 8 |
Corrigendum to “518 Poster - BluePrint molecular subtyping recognizes single and dual subtype tumors with consequences for therapeutic guidance” [Eur J Cancer 138 (Supplement 1) (October 2020) S106–S107]
|
Kuilman, Midas M.
|
|
|
174 |
C |
p. 328
|
artikel
|
| 9 |
Corrigendum to ‘Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients [European Journal of Cancer 163 (2022) 128–139]
|
Karsten, Maria M.
|
|
|
174 |
C |
p. 325-327
|
artikel
|
| 10 |
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences
|
Tabbò, Fabrizio
|
|
|
174 |
C |
p. 200-211
|
artikel
|
| 11 |
Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study
|
Goldrat, Oranite
|
|
|
174 |
C |
p. 134-141
|
artikel
|
| 12 |
Efficacy of cationic amphiphilic antihistamines on outcomes of patients treated with immune checkpoint inhibitors
|
Chiang, Cho-Han
|
|
|
174 |
C |
p. 1-9
|
artikel
|
| 13 |
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer
|
Oaknin, Ana
|
|
|
174 |
C |
p. 299-309
|
artikel
|
| 14 |
Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure
|
Yoon, Shinkyo
|
|
|
174 |
C |
p. 81-89
|
artikel
|
| 15 |
Follow-up strategy and survival for five common cancers: A meta-analysis
|
Galjart, Boris
|
|
|
174 |
C |
p. 185-199
|
artikel
|
| 16 |
HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications
|
Tarantino, Paolo
|
|
|
174 |
C |
p. 277-286
|
artikel
|
| 17 |
Ichthyosis associated with immune checkpoint blockade therapy: A novel cutaneous immune-related toxicity
|
Nikolaou, Vasiliki
|
|
|
174 |
C |
p. 78-80
|
artikel
|
| 18 |
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients
|
Foy, Jean-Philippe
|
|
|
174 |
C |
p. 287-298
|
artikel
|
| 19 |
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry
|
Santucci, Jordan
|
|
|
174 |
C |
p. 102-112
|
artikel
|
| 20 |
Incidence and Outcome of Breast Sarcomas in England (2013–2018): An analysis from the National Cancer Registration and Analysis Service
|
M, Ahmed
|
|
|
174 |
C |
p. 48-56
|
artikel
|
| 21 |
Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study
|
Mateos, María-Victoria
|
|
|
174 |
C |
p. 243-250
|
artikel
|
| 22 |
Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial
|
Lai, ZhiCheng
|
|
|
174 |
C |
p. 68-77
|
artikel
|
| 23 |
Letter re: “Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: A systematic review and Bayesian network meta-analysis”
|
Rizzo, Alessandro
|
|
|
174 |
C |
p. 321-322
|
artikel
|
| 24 |
Machine learning models demonstrate that clinicopathologic variables are comparable to gene expression prognostic signature in predicting survival in uveal melanoma
|
Donizy, Piotr
|
|
|
174 |
C |
p. 251-260
|
artikel
|
| 25 |
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial
|
González-Martín, Antonio
|
|
|
174 |
C |
p. 221-231
|
artikel
|
| 26 |
Metachronous malignancies after response to checkpoint inhibition
|
de Visser, Mirjam A.
|
|
|
174 |
C |
p. 99-101
|
artikel
|
| 27 |
New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC – Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas
|
Kantidakis, Georgios
|
|
|
174 |
C |
p. 261-276
|
artikel
|
| 28 |
Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) – A case series
|
Rausch, Christian
|
|
|
174 |
C |
p. 37-39
|
artikel
|
| 29 |
Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial
|
Villacampa, Guillermo
|
|
|
174 |
C |
p. 232-242
|
artikel
|
| 30 |
Re: Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial
|
Duan, Lei
|
|
|
174 |
C |
p. 310-312
|
artikel
|
| 31 |
Re: Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS Exon 19 deletion is not detected by the real-time PCR IdyllaTM EGFR mutation test but is detected by ctDNA NGS and responds to osimertinib
|
Bennett, Phil
|
|
|
174 |
C |
p. 315-317
|
artikel
|
| 32 |
Reply to comment on “Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: A systematic review and Bayesian network meta-analysis”
|
Sayed, Ahmed
|
|
|
174 |
C |
p. 323-324
|
artikel
|
| 33 |
Reporting of melanoma cell densities in the sentinel node refines outcome prediction
|
Ulmer, Anja
|
|
|
174 |
C |
p. 121-130
|
artikel
|
| 34 |
Response to letter entitled: Re: ‘Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial’
|
Shi, Changying
|
|
|
174 |
C |
p. 313-314
|
artikel
|
| 35 |
Response to letter entitled: Re: ‘Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR IdyllaTM EGFR mutation test but is detected by ctDNA NGS and responds to osimertinib'
|
O'Sullivan, Hazel
|
|
|
174 |
C |
p. 318-320
|
artikel
|
| 36 |
Safety and efficacy of S-IROX (S-1, irinotecan and oxaliplatin combination therapy) in patients with advanced pancreatic cancer: A multicenter phase 1b dose-escalation and dose-expansion clinical trial
|
Ohba, Akihiro
|
|
|
174 |
C |
p. 40-47
|
artikel
|
| 37 |
TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer
|
Koh, Jaemoon
|
|
|
174 |
C |
p. 10-20
|
artikel
|
| 38 |
The association of cardiac arrhythmias with chimeric antigen receptor T cell therapy in hospitalised patients: Insights from National Inpatient Sample
|
Thotamgari, Sahith Reddy
|
|
|
174 |
C |
p. 131-133
|
artikel
|
| 39 |
Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial
|
Chen, Si-Ye
|
|
|
174 |
C |
p. 153-164
|
artikel
|
| 40 |
Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database
|
Franko, Jan
|
|
|
174 |
C |
p. 142-152
|
artikel
|
| 41 |
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
|
Wang, Wenxian
|
|
|
174 |
C |
p. 21-30
|
artikel
|
Tijdschrift beschrijving